Complementary and alternative medicine among hospitalized pediatric patients

Adi Oren-Amit1, Matitiahu Berkovitch2, Hilla Bahat1

  • 1Pediatric Division, Assaf Harofeh Medical Center, Zerifin, Affiliated to the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Insights

Complementary and alternative medicine (CAM) use is common in hospitalized children, with over half of patients utilizing these therapies. Medical staff frequently overlook CAM use, highlighting the need for its inclusion in patient histories.

Area of Science:

  • Pediatric Health
  • Integrative Medicine

Background:

  • Complementary and alternative medicine (CAM) is increasingly utilized across various populations.
  • Understanding CAM use patterns in hospitalized children is crucial for comprehensive care.

Purpose of the Study:

  • To determine the prevalence and characteristics of CAM use in hospitalized children.
  • To assess pediatric medical staff's awareness of CAM utilization by patients.
  • To identify factors associated with CAM use in this demographic.

Main Methods:

  • A questionnaire was administered to parents of 146 children (aged 0-18) admitted to a pediatric division.
  • Medical charts were reviewed to verify documentation of CAM use.
  • Socio-demographic data and reasons for CAM use were collected.

Main Results:

  • Over half (54.3%) of the surveyed children used CAM, primarily for colic and teething.
  • CAM use was influenced by family, physicians, pharmacists, and friends.
  • Medical staff awareness and documentation of CAM use were very low (3.4% asked, 0% documented).
  • CAM use showed an inverse relationship with child's age and a correlation with belief in CAM.

Conclusions:

  • CAM use is prevalent among hospitalized pediatric patients.
  • Healthcare providers often overlook CAM use, indicating a gap in routine medical history taking.
  • Integrating CAM inquiries into standard medical practice is essential for patient safety and effective treatment.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
294